Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,779 | 370 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,149 | 127 | $0 (2024) |
| Lilly USA, LLC | $772.24 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $515.72 | 34 | $0 (2024) |
| Novo Nordisk Inc | $508.57 | 36 | $0 (2024) |
| Amgen Inc. | $374.92 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $330.94 | 17 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $260.28 | 14 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $118.44 | 7 | $0 (2024) |
| Amarin Pharma Inc. | $91.91 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $88.31 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,440 | 93 | ABBVIE INC. ($471.90) |
| 2023 | $1,504 | 93 | ABBVIE INC. ($693.36) |
| 2022 | $1,309 | 76 | ABBVIE INC. ($635.31) |
| 2021 | $1,526 | 108 | AbbVie Inc. ($348.05) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 13 | 14 | $1,974 | $360.28 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 14 | $1,974 | $360.28 | 18.3% |
About Erica Schweinsberg, PA-C
Erica Schweinsberg, PA-C is a Physician Assistant healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2018. The National Provider Identifier (NPI) number assigned to this provider is 1760968010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erica Schweinsberg, PA-C has received a total of $5,779 in payments from pharmaceutical and medical device companies, with $1,440 received in 2024. These payments were reported across 370 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,779).
As a Medicare-enrolled provider, Schweinsberg has provided services to 13 Medicare beneficiaries, totaling 14 services with total Medicare billing of $360.28. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Pittsburgh, PA
- Active Since 07/18/2018
- Last Updated 07/18/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1760968010
Products in Payments
- UBRELVY (Drug) $1,017
- QULIPTA (Drug) $576.83
- VRAYLAR (Drug) $530.50
- TRELEGY ELLIPTA (Drug) $486.01
- NURTEC ODT (Drug) $329.45
- MOUNJARO (Drug) $255.46
- JARDIANCE (Drug) $253.14
- FARXIGA (Drug) $251.66
- Ozempic (Drug) $216.13
- Otezla (Drug) $209.87
- Wegovy (Drug) $163.24
- Aimovig (Biological) $152.28
- TRULICITY (Drug) $152.09
- Rybelsus (Drug) $129.20
- EMGALITY (Drug) $121.70
- Kerendia (Drug) $118.44
- Vascepa (Drug) $91.91
- QUVIVIQ (Drug) $65.61
- Edarbi (Drug) $58.90
- STIOLTO RESPIMAT (Drug) $58.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pittsburgh
Dorissa Brivchik, Pa-C, PA-C
Physician Assistant — Payments: $66,021
Allyson Zella-Prater, Pac, PAC
Physician Assistant — Payments: $24,704
Margaret Bileck, Pa-C, Caq-Psy, PA-C, CAQ-PSY
Physician Assistant — Payments: $17,764
Mrs. Katherine Rubeo, Pa-C, PA-C
Physician Assistant — Payments: $15,114
Amanda Bembic, Pa-C, PA-C
Physician Assistant — Payments: $14,690
Mr. Daniel Porter, Pa-C, PA-C
Physician Assistant — Payments: $13,001